Xiao Bi-lian, von Hertzen H, Zhao Heng, Piaggio Gilda, Wu Shang-chun, Huang Jun, Weng Li-ju, Zhang Li-jia, Cheng Li-nan, Ren Fang-ming, He Chang-hai, Gui You-lun, Huang Zhen-jia, Lei Zhen-wu, Zhu Ming-hui, Song Li-juan, Cao Xiao-ming, Wang Rong-fen, Ding Wan-hua, Mei Qing-ming, Ni Feng-xian, Zheng Ning
National Research Institute for Family Planning, Beijing 100081, China.
Zhonghua Yi Xue Za Zhi. 2003 May 25;83(10):813-8.
To compare the effects of mifepristone of different doses on emergency contraception.
3,052 healthy women with regular menstrual cycle who visited the 10 family planning institutes and hospitals in Beijing, Shanghai, Shangdong, Sichuan, Tianjin, Guangdong, and Liaoning for emergency contraception within the period of 120 hours after a single act of unprotected sex were given a single dose of 10 mg or 25 mg mifepristone randomly and double-blindly. They were asked to record the vaginal hemorrhage that would occur and not to have unprotected sex until the next menstrual onset when they were followed up. The trial for a specific subject ended when she menstruated. If the menstruation was irregular or a specific subject failed to menstruate on time a blood or urine human chorionic gonadotropin (hCG) test was made. If the hCG test was negative, an appointment was made to follow up once one week later. If the hCG test was positive ultrasound examination was made to detect pregnancy. If the subject still failed to menstruate and the hCG test was still negative follow-up for this subject could be finished.
Twenty-two of the 3,052 subjects were lost to follow up. Among the remaining 3,030 women 1,516 were in the 10 mg group and 1 514 in the 25 mg group. Seventeen pregnancies occurred in each group, with a pregnancy rate of 1.1% for both groups. The relative risk of pregnancy of treatment of 25 mg mifepristone in comparison with treatment of 10 mg mifepristone was 1.0 (95% CI: 0.51-1.95). Both doses prevented about 85% approximately 86% of the anticipated pregnancy if no measure had been adopted. The pregnancy rate nearly doubled in the women who had unprotected sex after treatment of mifepristone. The efficacy of mifepristone decreased along with the delay of mifepristone administration. Side effects were uncommon and mild. Delay of 7 days or more in the onset of next menstruation occurred in 9%-10% of the women.
Mifepristone of the dose of 10 mg is safe and effective for emergency contraception. Earlier administration is preferable, although the method can be used effectively up to five days after the unprotected sex.
比较不同剂量米非司酮用于紧急避孕的效果。
3052名月经周期规律的健康女性,在单次无保护性行为后120小时内,前往北京、上海、山东、四川、天津、广东和辽宁的10家计划生育机构及医院寻求紧急避孕,被随机、双盲给予10毫克或25毫克单剂量米非司酮。要求她们记录可能出现的阴道出血情况,在随访期间直至下次月经来潮前不再进行无保护性行为。当特定受试者月经来潮时,该受试者的试验结束。如果月经不规律或特定受试者未按时月经来潮,则进行血液或尿液人绒毛膜促性腺激素(hCG)检测。如果hCG检测为阴性,预约一周后再次随访。如果hCG检测为阳性,则进行超声检查以检测是否怀孕。如果受试者仍未月经来潮且hCG检测仍为阴性,则可结束该受试者的随访。
3052名受试者中有22名失访。在其余3030名女性中,1516名在10毫克组,1514名在25毫克组。每组均发生17例妊娠,两组妊娠率均为1.1%。与10毫克米非司酮治疗相比,25毫克米非司酮治疗的妊娠相对风险为1.0(95%可信区间:0.51 - 1.95)。如果未采取任何措施,两种剂量均可预防约85%至86%的预期妊娠。米非司酮治疗后进行无保护性行为的女性妊娠率几乎翻倍。米非司酮的疗效随给药延迟而降低。副作用不常见且轻微。9%至10%的女性下次月经来潮延迟7天或更长时间。
10毫克剂量的米非司酮用于紧急避孕安全有效。尽管在无保护性行为后五天内使用该方法仍可有效,但尽早给药更佳。